As of Nov 30
| -0.03 / -0.11%|
The 2 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 27.50, with a high estimate of 28.00 and a low estimate of 27.00. The median estimate represents a +2.54% increase from the last price of 26.82.
The current consensus among 4 polled investment analysts is to Hold stock in Mindray Medical International Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.